Celestica CLS Q1 2026 Earnings EPS Surprises to the Upside as Shares Gain SUZ Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency and Favorable Pulp Market FFAI Q1 2026 Earnings Narrowed Losses Beat Estimates but No Revenue Reported and Stock Drops 981 Serina Therapeutics Inc SER Q1 2026 Earnings EPS Miss Amid Continued Development Progress ZGN Q4 2025 Earnings EPS Beat Drives Stock Higher Despite Revenue Disclosures Lacking HOVR Q1 2026 Earnings EPS Misses Estimates Despite Stock Surge